CClinicalTrials.gg
CompletedNCT01078831Updated Nov 11, 2010

Intrabronchial Airway Pressures in Intubated Patients During Bronchoscopy

An observational study in Acute Respiratory Distress Syndrome and Acute Lung Injury (ALI), sponsored by Oslo University Hospital. Completed at 1 site in Norway. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2010-11-11.

Sponsored by Oslo University Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The purpose of this study is to examine changes in ventilation and airway pressures during conventional bronchoscopy of intubated patients.

Read the detailed description

Mechanically ventilated patients often need bronchoscopy as a diagnostic procedure or for visually directed elimination of secretions. Partial endotracheal tube occlusion by the bronchoscope increases airflow resistance. Inhibition of inspiratory flow may be compensated for by augmented inspiratory pressure. Reduced expiratory flow however, cannot be compensated for by most ventilators and could lead to higher airway - and intrathoracic pressures that are not detected by pressure transducers in the ventilator tubing. In this study we compare changes in ventilation, airway pressures, ventilator pressures and blood gases during bronchoscopy of intubated patients in both volume controlled and pressure controlled ventilation. Our hypothesis are that 1) increased resistance in the tube during bronchoscopy leads to high intrabronchial airway pressures when the ventilator is in volume controlled mode, and 2) when the ventilator is in pressure controlled mode, increased resistance in the tube during bronchoscopy leads to reduced Tidal Volume and moderately increased paCO2.

02

Conditions studied

03

In context

Respiratory Distress Syndrome

1,596 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's planned enrollment of 20 is below the median of 100 across 540 observational studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

ARDS/ALI patients on mechanical ventilation where a therapeutic or diagnostic bronchoscopy has been requested by the staff physician.

Inclusion criteria

  • ARDS/ALI patients on mechanical ventilation
  • endotracheal tube size 7-9mm
  • age > 18 years
  • therapeutic or diagnostic bronchoscopy requested by staff physician

Exclusion criteria

Exclusion Criteria:

  • SpO2 \< 90%
  • unstable BP
  • pneumothorax
  • acute cardiovascular disease
  • cerebrovascular or other condition that requires stable BP and saturation
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
20 participants (estimated)
Biospecimen retention
Samples without dna

Groups and cohorts

  • ARDS / ALI patients

    Other: Bronchoscopy

Interventions

  • OtherBronchoscopy

    Airway pressures, ventilation changes and blood gas changes are recorded in a group of intubated patients on mechanical ventilation before and after bronchoscope insertion. The registration is done immediately before a therapeutic/diagnostic bronchoscopy requested by a staff physician not involved n the study.

06

What researchers measure

Primary outcomes

  1. Changes in ventilation, airway pressures and blood gases after bronchoscope insertion.

    paO2, paCO2 (kPa), airway and ventilator pressures (cmH2O)

    Time frame: 2 minutes after bronchoscope insertion/ mode change

07

Study locations

1 site
  • Oslo University Hospital - Ulleval
    Oslo, 0407, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 11, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01078831
Lead sponsor
Oslo University Hospital
First posted
Mar 2, 2010
Start date
Mar 2002
Primary completion
Apr 2010
Completion
Apr 2010
Last update
Nov 11, 2010

Study contacts

Helge Opdahl, MD, PhD
study director · Oslo University Hospital - Ulleval, Norway
Ole H Skjønsberg, MD, PhD
study director · Ullevaal University Hospital
Fredrik Borchsenius, MD
study director · Ullevaal University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion